Dana Farber has outlook revised to positive

Boston-based Dana Farber Cancer Institute had its outlook revised to positive amid strengthening operating performance, S&P Global said April 20.

Advertisement

The system, which in addition to its two main campuses operates six other centers in Massachusetts and New Hampshire, also had a series of bonds affirmed at “A.”

“The positive outlook reflects Dana Farber’s recently improved operating performance that, if maintained, could result in a higher rating assuming incremental balance sheet improvement and continued excellent fundraising results,” said Cynthia Keller, S&P Global credit analyst.

Operating income for the final quarter of 2022 totaled $51.6 million, up from $46.4 million in the corresponding 2021 period.

Advertisement

Next Up in Capital

Advertisement

Comments are closed.